COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00346281
Recruitment Status : Unknown
Verified June 2006 by pSiMedica Limited.
Recruitment status was:  Recruiting
First Posted : June 29, 2006
Last Update Posted : June 29, 2006
pSiOncology Private Limited
Singapore General Hospital
Guy's and St Thomas' NHS Foundation Trust
Information provided by:
pSiMedica Limited

No Study Results Posted on for this Study
Recruitment Status : Unknown
Primary Completion Date : No date given
Study Completion Date : June 2008